Establishment and validation of a prognostic nomogram for long-term low vision after diabetic vitrectomy

Front Endocrinol (Lausanne). 2023 Aug 25:14:1196335. doi: 10.3389/fendo.2023.1196335. eCollection 2023.

Abstract

Purpose: We aimed to evaluate the risk factors and develop a prognostic nomogram of long-term low vision after diabetic vitrectomy.

Methods: This retrospective study included 186 patients (250 eyes) that underwent primary vitrectomy for proliferative diabetic retinopathy with a minimum follow-up period of one year. Patients were assigned to the training cohort (200 eyes) or validation cohort (50 eyes) at a 4:1 ratio randomly. Based on a cutoff value of 0.3 in best-corrected visual acuity (BCVA) measurement, the training cohort was separated into groups with or without low vision. Univariate and multivariate logistic regression analyses were performed on preoperative systemic and ocular characteristics to develop a risk prediction model and nomogram. The calibration curve and the area under the receiver operating characteristic curves (AUC) were used to evaluate the calibration and discrimination of the model. The nomogram was internally validated using the bootstrapping method, and it was further verified in an external cohort.

Results: Four independent risk factors were selected by stepwise forward regression, including tractional retinal detachment (β=1.443, OR=4.235, P<0.001), symptom duration ≥6 months (β=0.954, OR=2.595, P=0.004), preoperative BCVA measurement (β=0.540, OR=1.716, P=0.033), and hypertension (β=0.645, OR=1.905, P=0.044). AUC values of 0.764 (95% CI: 0.699-0.829) in the training cohort and 0.755 (95% CI: 0.619-0.891) in the validation cohort indicated the good predictive ability of the model.

Conclusion: The prognostic nomogram established in this study is useful for predicting long-term low vision after diabetic vitrectomy.

Keywords: low vision; nomogram; proliferative diabetic retinopathy; risk prediction model; vitrectomy.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus*
  • Diabetic Retinopathy* / diagnosis
  • Diabetic Retinopathy* / surgery
  • Humans
  • Nomograms
  • Prognosis
  • Retrospective Studies
  • Vision, Low*
  • Vitrectomy

Grants and funding

Funded by Tianjin Key Medical Discipline (Specialty) Construction Project (No.TJYXZDXK-037A), Natural Science Foundation of Tianjin City (No.20JCZXJC00040), and the Science & Technology Development Fund of Tianjin Education Commission for Higher Education (No.2022ZD058).